Spider Rock Advisors, LLC Eli Lilly & CO Put Options Transaction History

Spider Rock Advisors, LLC

$6.17 Billion
Q3 2024

Put Options

21 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 01, 2024	BUY	$772.14 - $960.02 $5.02 Million - $6.24 Million	6,500 Added 17.52%	43,600 $38.6 Million
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $3.7 Million - $4.64 Million	-5,100 Reduced 12.09%	37,100 $33.6 Million
Q1 2024 Apr 30, 2024	SELL	$592.2 - $792.28 $12.6 Million - $16.9 Million	-21,300 Reduced 33.54%	42,200 $32.8 Million
Q4 2023 Jan 30, 2024	BUY	$525.19 - $619.13 $11.1 Million - $13.1 Million	21,200 Added 50.12%	63,500 $30.2 Million
Q3 2023 Oct 25, 2023	BUY	$434.7 - $599.3 $11.4 Million - $15.7 Million	26,200 Added 162.73%	42,300 $19.2 Million
Q2 2023 Jul 31, 2023	SELL	$350.74 - $468.98 $596,258 - $797,266	-1,700 Reduced 9.55%	16,100 $4.91 Million
Q1 2023 Apr 24, 2023	SELL	$310.63 - $364.82 $248,504 - $291,856	-800 Reduced 4.3%	17,800 $5.21 Million
Q4 2022 Feb 07, 2023	SELL	$321.55 - $374.67 $15.5 Million - $18.1 Million	-48,300 Reduced 72.2%	18,600 $4.7 Million
Q3 2022 Nov 04, 2022	SELL	$296.48 - $337.87 $2.76 Million - $3.14 Million	-9,300 Reduced 12.2%	66,900 $15.2 Million
Q1 2022 May 06, 2022	BUY	$234.69 - $291.66 $821,415 - $1.02 Million	3,500 Added 4.81%	76,200 $16.3 Million
Q4 2021 Feb 08, 2022	SELL	$224.85 - $279.04 $1.37 Million - $1.7 Million	-6,100 Reduced 7.74%	72,700 $15.5 Million
Q3 2021 Oct 19, 2021	BUY	$221.6 - $272.71 $110,800 - $136,355	500 Added 0.64%	78,800 $15.5 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $1.82 Million - $2.36 Million	-10,100 Reduced 11.43%	78,300 $10.1 Million
Q4 2020 Jan 28, 2021	SELL	$130.46 - $172.63 $130,460 - $172,630	-1,000 Reduced 1.12%	88,400 $11 Million
Q3 2020 Oct 16, 2020	SELL	$146.22 - $169.13 $877,320 - $1.01 Million	-6,000 Reduced 6.29%	89,400 $11.2 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $22.9 Million - $27.6 Million	-168,200 Reduced 63.81%	95,400 $823,000
Q1 2020 May 11, 2020	BUY	$119.05 - $147.35 $29.6 Million - $36.7 Million	248,900 Added 1693.2%	263,600 $4.18 Million
Q3 2019 Oct 28, 2019	BUY	$106.79 - $116.16 $309,691 - $336,864	2,900 Added 24.58%	14,700 $21,000
Q4 2018 Feb 08, 2019	BUY	$105.9 - $118.64 $1.25 Million - $1.4 Million	11,800 New	11,800 $37,000
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $3.2 Million - $3.44 Million	-39,100 Closed	0 $0
Q3 2017 Oct 18, 2017	BUY	$77.07 - $85.54 $3.01 Million - $3.34 Million	39,100	39,100 $12,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$77.1 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$58.7 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$52.4 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$40.9 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$26.9 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Spider Rock Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spider Rock Advisors, LLC with notifications on news.

Account